Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxcarbazepine pharmacogenetic study in epilepsy
ChiCTR-OCH-14004528Phase 4Completed
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxcarbazepine in epilepsy (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoint: Plasma drug concentration. Started Apr 2014; status: completed.
02
Drugs
oxcarbazepine
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR-OCH-14004528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-14004528.